Toxoplasmosis Treatment in HIV/AIDS: Standard Regimen and Supportive Care
Toxoplasmic encephalitis (TE) in HIV/AIDS (CD4 <100) requires prompt, coordinated therapy.
First-Line Therapy (Acute Treatment, ≥6 weeks)
- Pyrimethamine 200 mg loading dose, then 50–75 mg/day (adjust for weight).
- Sulfadiazine 1–1.5 g QID (total 4–6 g/day).
- Leucovorin (folinic acid) 10–25 mg/day with each pyrimethamine dose—prevents bone marrow suppression.
Alternative if sulfa-allergic: Pyrimethamine + clindamycin 600 mg IV/PO QID ± leucovorin.
Adjunctive Therapy for Severe TE
- Corticosteroids (dexamethasone 4 mg Q6H) for mass effect/edema—taper as imaging improves.
- Anticonvulsants for seizure prophylaxis/treatment (levetiracetam preferred).
Maintenance Therapy (Secondary Prophylaxis)
Continue pyrimethamine 25–50 mg + sulfadiazine 2–4 g + leucovorin daily until CD4 >200 for ≥6 months on ART.
Supportive Care
- ART initiation (if not on it)—ideally within 2 weeks of TE treatment (IRIS risk).
- Monitor CBC weekly × 2, then biweekly (neutropenia, thrombocytopenia).
- Hydration, nutrition, electrolytes.
- Serial imaging (MRI/CT) to assess response.
Primary Prophylaxis
TMP-SMX (Bactrim DS daily) if CD4 <100—also prevents PCP. Alternatives: dapsone, atovaquone.
Multidisciplinary care (ID, neurology, HIV) optimizes outcomes.
HIV & AIDS - Related Articles
- IT Grants for HIV/AIDS Initiatives: Funding Opportunities
- Understanding HIV Testing Methods: A Comprehensive Guide
- Gerard Way's Health: Addressing Rumors and Misinformation
- Understanding HIV and AIDS Diagnosis: What You Need to Know
- Understanding Western Blot HIV Test Results: A Comprehensive Guide
- Bedmaking for Incontinent Patients: Linens and Pads
- Do HIV Antibodies Ever Disappear?
